Ezgi Kaya-Aksoy

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase

Dietrich Alexander Ruess, Guus J.J.E. Heynen, Katrin J. Ciecielski et al. · Nature Medicine · 2018 · 373 citations

Medicine, Molecular Biology, Oncology +14

Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice

Kıvanç Görgülü, Kalliope N. Diakopoulos, Jiaoyu Ai et al. · Gastroenterology · 2018 · 85 citations

Medicine, Cancer Biology, Oncology +15

The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme

Ezgi Kaya-Aksoy, Ahmet Cingöz, Filiz Senbabaoglu et al. · Cell Death Discovery · 2019 · 47 citations · Full text

Medicine, Cell Biology, Oncology +17

Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer

Katrin J. Frank, Antonio Mulero‐Sánchez, Alexandra Berninger et al. · Cell Reports Medicine · 2022 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15

KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL

Ibrahim Cagri Kurt, İlknur Sur‐Erdem, Ezgi Kaya-Aksoy et al. · Cell Death and Disease · 2017 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +17